PHA-793887 25 mg | 100.00%
TargetMol
PHA-793887 has been used in trials studying the treatment of Advanced/Metastatic Solid Tumors.
More Information Supplier PagePHA-793887
Search Results
FH1 200 mg | 99.95%
TargetMol
FH1 (BRD-K4477), a small molecule, enhances the functions of hepatocytes and promotes differentiation hepatocytes derived by iPS.
More Information Supplier PageFH1
FH1 100 mg | 99.95%
TargetMol
FH1 (BRD-K4477), a small molecule, enhances the functions of hepatocytes and promotes differentiation hepatocytes derived by iPS.
More Information Supplier PageFH1
Navitoclax 200 mg | 98.88%
TargetMol
Navitoclax (ABT-263) is a potent, orally bioavailable Bcl-2 family protein inhibitor that avidly binds Bcl-2, Bcl-xL, and Bcl-W (Ki < 1 nM for all three proteins).
More Information Supplier PageNavitoclax
Yohimbine hydrochloride 200 mg | 99.98%
TargetMol
Yohimbine hydrochloride (Antagonil) is a plant alkaloid with alpha-2-adrenergic blocking activity. Yohimbine has been used as a mydriatic and in the treatment of ERECTILE DYSFUNCTION.
More Information Supplier PageYohimbine hydrochloride
Temsirolimus 5 mg | 97.69%
TargetMol
Temsirolimus is a specific mTOR inhibitor ( IC50: 1.76 μM), used in the treatment of advanced renal cell cancer.
More Information Supplier PageTemsirolimus
8-Azaguanine 100 mg | Purity Not Available
TargetMol
8-Azaguanine is a purine analogue with potential antineoplastic activity.
More Information Supplier Page8-Azaguanine
Orthanilamide 200 mg | Purity Not Available
TargetMol
2-Aminobenzenesulfonamide is a molecule containing the sulfonamide functional group attached to an aniline.
More Information Supplier Page2-(1,8-naphthyridin-2-yl)phenol 100 mg | 99.84%
TargetMol
2-(1,8-naphthyridin-2-yl)phenol
CaMKP Inhibitor 100 mg | 96.55%
TargetMol
CaMKP Inhibitor
